A previous study identified Rgs4 as a novel target of mTOR inhibition in a mouse glioma model31 and since the PI3K/Akt that mediates Rgs4 activity is one of the major drivers of mTOR activity, we wondered whether Rgs4 is required for mTOR activation in vivo. The gene discussed is AKT1; the disease is central nervous system cancer.